US Stock MarketDetailed Quotes

BMY Bristol-Myers Squibb

Watchlist
  • 55.780
  • -0.500-0.89%
Close Dec 13 16:00 ET
  • 55.700
  • -0.080-0.14%
Post 20:01 ET
113.13BMarket Cap-15.58P/E (TTM)

Bristol-Myers Squibb Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments
5.32%8.09B
-23.79%6.65B
4.33%9.67B
32.71%12.28B
32.71%12.28B
-14.87%7.69B
-34.19%8.73B
-39.00%9.27B
-46.27%9.25B
-46.27%9.25B
-Cash and cash equivalents
5.00%7.89B
-24.83%6.29B
3.72%9.33B
25.66%11.46B
25.66%11.46B
-2.84%7.51B
-22.12%8.37B
-27.28%9B
-34.74%9.12B
-34.74%9.12B
-Short-term investments
19.30%204M
0.56%360M
24.09%340M
527.69%816M
527.69%816M
-86.77%171M
-85.77%358M
-90.31%274M
-95.99%130M
-95.99%130M
Receivables
-4.81%14.9B
0.58%15.15B
4.89%14.06B
9.52%15.26B
9.52%15.26B
18.18%15.65B
20.09%15.06B
20.73%13.41B
11.35%13.94B
11.35%13.94B
-Accounts receivable
10.82%9.32B
19.95%9.75B
12.38%8.83B
8.97%8.88B
8.97%8.88B
4.81%8.41B
7.11%8.13B
9.75%7.85B
2.16%8.15B
2.16%8.15B
-Taxes receivable
-29.54%3.48B
-26.53%3.34B
12.61%3.21B
10.71%3.93B
10.71%3.93B
55.08%4.93B
48.09%4.54B
30.43%2.85B
27.32%3.55B
27.32%3.55B
-Other receivables
-8.89%2.1B
-13.75%2.06B
-24.99%2.03B
9.65%2.46B
9.65%2.46B
13.20%2.31B
26.76%2.39B
53.26%2.71B
27.87%2.24B
27.87%2.24B
Inventory
36.78%3.33B
30.16%3.08B
14.59%2.99B
13.81%2.66B
13.81%2.66B
17.45%2.44B
10.36%2.36B
23.81%2.61B
11.65%2.34B
11.65%2.34B
Restricted cash
-96.30%2M
-96.23%2M
-96.23%2M
-62.84%55M
-62.84%55M
-67.07%54M
-65.36%53M
-65.81%53M
5.71%148M
5.71%148M
Other current assets
-3.20%1.75B
7.71%2.01B
11.29%1.95B
-5.45%1.51B
-5.45%1.51B
-21.00%1.81B
-10.41%1.87B
12.22%1.75B
23.72%1.6B
23.72%1.6B
Total current assets
1.60%28.08B
-4.22%26.89B
5.84%28.67B
16.49%31.77B
16.49%31.77B
3.12%27.63B
-7.00%28.07B
-10.08%27.09B
-18.01%27.27B
-18.01%27.27B
Non current assets
Net PPE
5.14%8.25B
6.97%8.16B
7.64%8.19B
7.51%8.04B
7.51%8.04B
13.44%7.85B
12.03%7.63B
9.57%7.61B
7.28%7.48B
7.28%7.48B
-Gross PPE
4.70%13.09B
9.43%13.25B
10.82%13.13B
10.31%12.84B
10.31%12.84B
13.04%12.5B
11.73%12.11B
6.64%11.85B
5.80%11.64B
5.80%11.64B
-Accumulated depreciation
-3.98%-4.84B
-13.63%-5.09B
-16.53%-4.94B
-15.35%-4.8B
-15.35%-4.8B
-12.37%-4.65B
-11.23%-4.48B
-1.78%-4.24B
-3.25%-4.16B
-3.25%-4.16B
Goodwill and other intangible assets
-2.86%49.08B
-2.58%51.57B
-0.56%54.91B
-15.39%48.65B
-15.39%48.65B
-15.57%50.52B
-9.83%52.94B
-9.37%55.22B
-9.12%57.5B
-9.12%57.5B
-Goodwill
2.86%21.75B
2.69%21.73B
2.72%21.74B
0.09%21.17B
0.09%21.17B
0.17%21.15B
3.51%21.16B
3.23%21.16B
3.16%21.15B
3.16%21.15B
-Other intangible assets
-6.98%27.33B
-6.09%29.84B
-2.60%33.17B
-24.40%27.49B
-24.40%27.49B
-24.14%29.38B
-16.96%31.77B
-15.75%34.05B
-15.01%36.36B
-15.01%36.36B
Investments and advances
23.29%2.85B
50.63%3B
43.89%2.89B
14.27%2.5B
14.27%2.5B
18.12%2.31B
0.91%1.99B
-8.24%2.01B
-19.39%2.19B
-19.39%2.19B
Non current deferred assets
138.38%3.61B
111.39%3.32B
106.76%2.72B
105.95%2.77B
105.95%2.77B
13.92%1.51B
17.58%1.57B
-7.12%1.32B
-6.60%1.34B
-6.60%1.34B
Defined pension benefit
-23.99%225M
-29.53%210M
-3.01%290M
-0.35%284M
-0.35%284M
-1.66%296M
-5.40%298M
-6.85%299M
-10.09%285M
-10.09%285M
Other non current assets
39.12%1.58B
50.86%1.49B
82.34%1.37B
52.66%1.15B
52.66%1.15B
7.58%1.14B
-3.79%989M
-33.13%753M
-43.80%752M
-43.80%752M
Total non current assets
3.09%65.6B
3.58%67.76B
4.71%70.36B
-8.85%63.39B
-8.85%63.39B
-10.88%63.63B
-6.78%65.42B
-7.84%67.2B
-8.55%69.55B
-8.55%69.55B
Total assets
2.64%93.67B
1.24%94.65B
5.04%99.03B
-1.72%95.16B
-1.72%95.16B
-7.06%91.26B
-6.84%93.49B
-8.50%94.28B
-11.43%96.82B
-11.43%96.82B
Liabilities
Current liabilities
Payables
13.70%6.18B
11.34%6.44B
11.46%6.24B
12.84%5.84B
12.84%5.84B
7.97%5.43B
11.76%5.79B
11.44%5.6B
5.91%5.18B
5.91%5.18B
-accounts payable
23.32%3.47B
22.22%3.75B
10.80%3.54B
7.20%3.26B
7.20%3.26B
8.40%2.81B
6.49%3.07B
8.49%3.19B
3.09%3.04B
3.09%3.04B
-Total tax payable
2.13%1.49B
-3.41%1.47B
22.99%1.49B
45.54%1.37B
45.54%1.37B
13.29%1.46B
33.74%1.53B
30.00%1.21B
24.93%942M
24.93%942M
-Dividends payable
4.91%1.22B
2.18%1.22B
1.59%1.22B
1.42%1.21B
1.42%1.21B
1.05%1.16B
3.21%1.19B
4.00%1.2B
0.84%1.2B
0.84%1.2B
Current accrued expenses
38.01%512M
94.41%591M
71.16%546M
8.72%349M
8.72%349M
19.29%371M
-13.64%304M
-10.39%319M
-15.08%321M
-15.08%321M
Current debt and capital lease obligation
-77.87%1.24B
16.31%3.71B
117.55%6.36B
-25.43%3.28B
-25.43%3.28B
144.32%5.62B
-37.73%3.19B
-62.00%2.92B
-14.01%4.4B
-14.01%4.4B
-Current debt
-80.28%1.08B
16.92%3.53B
124.93%6.19B
-26.85%3.12B
-26.85%3.12B
156.43%5.47B
-39.03%3.02B
-63.41%2.75B
-13.82%4.26B
-13.82%4.26B
-Current capital lease obligation
10.00%165M
5.36%177M
-1.17%169M
19.12%162M
19.12%162M
-10.18%150M
0.60%168M
0.00%171M
-19.53%136M
-19.53%136M
Other current liabilities
20.27%13.43B
14.86%11.6B
24.96%12.06B
8.82%11.5B
8.82%11.5B
8.61%11.17B
6.68%10.1B
6.26%9.65B
4.52%10.57B
4.52%10.57B
Current liabilities
-3.51%22.64B
15.46%23.27B
35.30%25.82B
1.70%22.26B
1.70%22.26B
23.94%23.46B
-3.66%20.15B
-16.37%19.09B
0.10%21.89B
0.10%21.89B
Non current liabilities
Long term debt and capital lease obligation
49.05%50.16B
39.72%50.3B
40.06%51.05B
5.14%38.18B
5.14%38.18B
-11.00%33.65B
-5.07%36B
-4.84%36.45B
-10.28%36.32B
-10.28%36.32B
-Long term debt
51.46%48.67B
40.98%48.86B
41.08%49.49B
4.56%36.65B
4.56%36.65B
-13.06%32.14B
-6.61%34.66B
-6.33%35.08B
-11.49%35.06B
-11.49%35.06B
-Long term capital lease obligation
-1.98%1.48B
7.15%1.44B
14.09%1.56B
21.33%1.53B
21.33%1.53B
79.05%1.51B
64.66%1.34B
60.80%1.37B
44.28%1.26B
44.28%1.26B
Non current deferred liabilities
5.00%1.15B
-18.09%1.19B
-47.33%1.19B
-61.94%1.07B
-61.94%1.07B
-68.73%1.1B
-60.65%1.45B
-50.12%2.26B
-46.75%2.8B
-46.75%2.8B
Employee benefits
15.80%447M
17.09%466M
19.55%477M
19.40%480M
19.40%480M
-30.20%386M
-32.43%398M
-36.16%399M
-38.53%402M
-38.53%402M
Other non current liabilities
36.50%531M
96.59%576M
98.63%582M
30.69%396M
30.69%396M
51.95%389M
40.19%293M
36.28%293M
38.99%303M
38.99%303M
Total non current liabilities
38.96%53.83B
31.48%54.31B
30.83%56.66B
-0.91%43.41B
-0.91%43.41B
-16.75%38.74B
-11.70%41.31B
-10.83%43.31B
-14.83%43.81B
-14.83%43.81B
Total liabilities
22.94%76.47B
26.23%77.58B
32.19%82.48B
-0.04%65.67B
-0.04%65.67B
-4.98%62.2B
-9.21%61.46B
-12.60%62.4B
-10.38%65.7B
-10.38%65.7B
Shareholders'equity
Share capital
0.00%292M
0.00%292M
0.00%292M
0.00%292M
0.00%292M
0.00%292M
0.00%292M
0.00%292M
0.00%292M
0.00%292M
-common stock
0.00%292M
0.00%292M
0.00%292M
0.00%292M
0.00%292M
0.00%292M
0.00%292M
0.00%292M
0.00%292M
0.00%292M
-Preferred stock
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Retained earnings
-42.95%16.1B
-41.33%16.1B
-41.13%15.64B
12.79%28.77B
12.79%28.77B
14.36%28.22B
13.35%27.45B
10.94%26.57B
7.07%25.5B
7.07%25.5B
Paid-in capital
2.33%45.9B
1.03%45.77B
1.14%45.66B
1.15%45.68B
1.15%45.68B
-0.24%44.85B
2.08%45.3B
3.16%45.14B
1.81%45.17B
1.81%45.17B
Less: Treasury stock
1.39%43.68B
10.11%43.69B
12.60%43.7B
13.33%43.77B
13.33%43.77B
18.30%43.08B
12.43%39.68B
10.29%38.81B
23.54%38.62B
23.54%38.62B
Gains losses not affecting retained earnings
-14.15%-1.47B
-4.97%-1.46B
-2.34%-1.4B
-20.69%-1.55B
-20.69%-1.55B
-52.91%-1.29B
-39.82%-1.39B
-11.31%-1.37B
-1.03%-1.28B
-1.03%-1.28B
Total stockholders'equity
-40.89%17.14B
-46.78%17.02B
-48.18%16.49B
-5.25%29.43B
-5.25%29.43B
-11.24%29B
-1.92%31.97B
0.77%31.82B
-13.59%31.06B
-13.59%31.06B
Noncontrolling interests
-9.38%58M
-5.26%54M
-6.45%58M
-3.51%55M
-3.51%55M
1.59%64M
-6.56%57M
-4.62%62M
-5.00%57M
-5.00%57M
Total equity
-40.82%17.2B
-46.71%17.07B
-48.10%16.55B
-5.25%29.49B
-5.25%29.49B
-11.22%29.06B
-1.93%32.03B
0.76%31.89B
-13.58%31.12B
-13.58%31.12B
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments 5.32%8.09B-23.79%6.65B4.33%9.67B32.71%12.28B32.71%12.28B-14.87%7.69B-34.19%8.73B-39.00%9.27B-46.27%9.25B-46.27%9.25B
-Cash and cash equivalents 5.00%7.89B-24.83%6.29B3.72%9.33B25.66%11.46B25.66%11.46B-2.84%7.51B-22.12%8.37B-27.28%9B-34.74%9.12B-34.74%9.12B
-Short-term investments 19.30%204M0.56%360M24.09%340M527.69%816M527.69%816M-86.77%171M-85.77%358M-90.31%274M-95.99%130M-95.99%130M
Receivables -4.81%14.9B0.58%15.15B4.89%14.06B9.52%15.26B9.52%15.26B18.18%15.65B20.09%15.06B20.73%13.41B11.35%13.94B11.35%13.94B
-Accounts receivable 10.82%9.32B19.95%9.75B12.38%8.83B8.97%8.88B8.97%8.88B4.81%8.41B7.11%8.13B9.75%7.85B2.16%8.15B2.16%8.15B
-Taxes receivable -29.54%3.48B-26.53%3.34B12.61%3.21B10.71%3.93B10.71%3.93B55.08%4.93B48.09%4.54B30.43%2.85B27.32%3.55B27.32%3.55B
-Other receivables -8.89%2.1B-13.75%2.06B-24.99%2.03B9.65%2.46B9.65%2.46B13.20%2.31B26.76%2.39B53.26%2.71B27.87%2.24B27.87%2.24B
Inventory 36.78%3.33B30.16%3.08B14.59%2.99B13.81%2.66B13.81%2.66B17.45%2.44B10.36%2.36B23.81%2.61B11.65%2.34B11.65%2.34B
Restricted cash -96.30%2M-96.23%2M-96.23%2M-62.84%55M-62.84%55M-67.07%54M-65.36%53M-65.81%53M5.71%148M5.71%148M
Other current assets -3.20%1.75B7.71%2.01B11.29%1.95B-5.45%1.51B-5.45%1.51B-21.00%1.81B-10.41%1.87B12.22%1.75B23.72%1.6B23.72%1.6B
Total current assets 1.60%28.08B-4.22%26.89B5.84%28.67B16.49%31.77B16.49%31.77B3.12%27.63B-7.00%28.07B-10.08%27.09B-18.01%27.27B-18.01%27.27B
Non current assets
Net PPE 5.14%8.25B6.97%8.16B7.64%8.19B7.51%8.04B7.51%8.04B13.44%7.85B12.03%7.63B9.57%7.61B7.28%7.48B7.28%7.48B
-Gross PPE 4.70%13.09B9.43%13.25B10.82%13.13B10.31%12.84B10.31%12.84B13.04%12.5B11.73%12.11B6.64%11.85B5.80%11.64B5.80%11.64B
-Accumulated depreciation -3.98%-4.84B-13.63%-5.09B-16.53%-4.94B-15.35%-4.8B-15.35%-4.8B-12.37%-4.65B-11.23%-4.48B-1.78%-4.24B-3.25%-4.16B-3.25%-4.16B
Goodwill and other intangible assets -2.86%49.08B-2.58%51.57B-0.56%54.91B-15.39%48.65B-15.39%48.65B-15.57%50.52B-9.83%52.94B-9.37%55.22B-9.12%57.5B-9.12%57.5B
-Goodwill 2.86%21.75B2.69%21.73B2.72%21.74B0.09%21.17B0.09%21.17B0.17%21.15B3.51%21.16B3.23%21.16B3.16%21.15B3.16%21.15B
-Other intangible assets -6.98%27.33B-6.09%29.84B-2.60%33.17B-24.40%27.49B-24.40%27.49B-24.14%29.38B-16.96%31.77B-15.75%34.05B-15.01%36.36B-15.01%36.36B
Investments and advances 23.29%2.85B50.63%3B43.89%2.89B14.27%2.5B14.27%2.5B18.12%2.31B0.91%1.99B-8.24%2.01B-19.39%2.19B-19.39%2.19B
Non current deferred assets 138.38%3.61B111.39%3.32B106.76%2.72B105.95%2.77B105.95%2.77B13.92%1.51B17.58%1.57B-7.12%1.32B-6.60%1.34B-6.60%1.34B
Defined pension benefit -23.99%225M-29.53%210M-3.01%290M-0.35%284M-0.35%284M-1.66%296M-5.40%298M-6.85%299M-10.09%285M-10.09%285M
Other non current assets 39.12%1.58B50.86%1.49B82.34%1.37B52.66%1.15B52.66%1.15B7.58%1.14B-3.79%989M-33.13%753M-43.80%752M-43.80%752M
Total non current assets 3.09%65.6B3.58%67.76B4.71%70.36B-8.85%63.39B-8.85%63.39B-10.88%63.63B-6.78%65.42B-7.84%67.2B-8.55%69.55B-8.55%69.55B
Total assets 2.64%93.67B1.24%94.65B5.04%99.03B-1.72%95.16B-1.72%95.16B-7.06%91.26B-6.84%93.49B-8.50%94.28B-11.43%96.82B-11.43%96.82B
Liabilities
Current liabilities
Payables 13.70%6.18B11.34%6.44B11.46%6.24B12.84%5.84B12.84%5.84B7.97%5.43B11.76%5.79B11.44%5.6B5.91%5.18B5.91%5.18B
-accounts payable 23.32%3.47B22.22%3.75B10.80%3.54B7.20%3.26B7.20%3.26B8.40%2.81B6.49%3.07B8.49%3.19B3.09%3.04B3.09%3.04B
-Total tax payable 2.13%1.49B-3.41%1.47B22.99%1.49B45.54%1.37B45.54%1.37B13.29%1.46B33.74%1.53B30.00%1.21B24.93%942M24.93%942M
-Dividends payable 4.91%1.22B2.18%1.22B1.59%1.22B1.42%1.21B1.42%1.21B1.05%1.16B3.21%1.19B4.00%1.2B0.84%1.2B0.84%1.2B
Current accrued expenses 38.01%512M94.41%591M71.16%546M8.72%349M8.72%349M19.29%371M-13.64%304M-10.39%319M-15.08%321M-15.08%321M
Current debt and capital lease obligation -77.87%1.24B16.31%3.71B117.55%6.36B-25.43%3.28B-25.43%3.28B144.32%5.62B-37.73%3.19B-62.00%2.92B-14.01%4.4B-14.01%4.4B
-Current debt -80.28%1.08B16.92%3.53B124.93%6.19B-26.85%3.12B-26.85%3.12B156.43%5.47B-39.03%3.02B-63.41%2.75B-13.82%4.26B-13.82%4.26B
-Current capital lease obligation 10.00%165M5.36%177M-1.17%169M19.12%162M19.12%162M-10.18%150M0.60%168M0.00%171M-19.53%136M-19.53%136M
Other current liabilities 20.27%13.43B14.86%11.6B24.96%12.06B8.82%11.5B8.82%11.5B8.61%11.17B6.68%10.1B6.26%9.65B4.52%10.57B4.52%10.57B
Current liabilities -3.51%22.64B15.46%23.27B35.30%25.82B1.70%22.26B1.70%22.26B23.94%23.46B-3.66%20.15B-16.37%19.09B0.10%21.89B0.10%21.89B
Non current liabilities
Long term debt and capital lease obligation 49.05%50.16B39.72%50.3B40.06%51.05B5.14%38.18B5.14%38.18B-11.00%33.65B-5.07%36B-4.84%36.45B-10.28%36.32B-10.28%36.32B
-Long term debt 51.46%48.67B40.98%48.86B41.08%49.49B4.56%36.65B4.56%36.65B-13.06%32.14B-6.61%34.66B-6.33%35.08B-11.49%35.06B-11.49%35.06B
-Long term capital lease obligation -1.98%1.48B7.15%1.44B14.09%1.56B21.33%1.53B21.33%1.53B79.05%1.51B64.66%1.34B60.80%1.37B44.28%1.26B44.28%1.26B
Non current deferred liabilities 5.00%1.15B-18.09%1.19B-47.33%1.19B-61.94%1.07B-61.94%1.07B-68.73%1.1B-60.65%1.45B-50.12%2.26B-46.75%2.8B-46.75%2.8B
Employee benefits 15.80%447M17.09%466M19.55%477M19.40%480M19.40%480M-30.20%386M-32.43%398M-36.16%399M-38.53%402M-38.53%402M
Other non current liabilities 36.50%531M96.59%576M98.63%582M30.69%396M30.69%396M51.95%389M40.19%293M36.28%293M38.99%303M38.99%303M
Total non current liabilities 38.96%53.83B31.48%54.31B30.83%56.66B-0.91%43.41B-0.91%43.41B-16.75%38.74B-11.70%41.31B-10.83%43.31B-14.83%43.81B-14.83%43.81B
Total liabilities 22.94%76.47B26.23%77.58B32.19%82.48B-0.04%65.67B-0.04%65.67B-4.98%62.2B-9.21%61.46B-12.60%62.4B-10.38%65.7B-10.38%65.7B
Shareholders'equity
Share capital 0.00%292M0.00%292M0.00%292M0.00%292M0.00%292M0.00%292M0.00%292M0.00%292M0.00%292M0.00%292M
-common stock 0.00%292M0.00%292M0.00%292M0.00%292M0.00%292M0.00%292M0.00%292M0.00%292M0.00%292M0.00%292M
-Preferred stock --0--0--0--0--0--0--0--0--0--0
Retained earnings -42.95%16.1B-41.33%16.1B-41.13%15.64B12.79%28.77B12.79%28.77B14.36%28.22B13.35%27.45B10.94%26.57B7.07%25.5B7.07%25.5B
Paid-in capital 2.33%45.9B1.03%45.77B1.14%45.66B1.15%45.68B1.15%45.68B-0.24%44.85B2.08%45.3B3.16%45.14B1.81%45.17B1.81%45.17B
Less: Treasury stock 1.39%43.68B10.11%43.69B12.60%43.7B13.33%43.77B13.33%43.77B18.30%43.08B12.43%39.68B10.29%38.81B23.54%38.62B23.54%38.62B
Gains losses not affecting retained earnings -14.15%-1.47B-4.97%-1.46B-2.34%-1.4B-20.69%-1.55B-20.69%-1.55B-52.91%-1.29B-39.82%-1.39B-11.31%-1.37B-1.03%-1.28B-1.03%-1.28B
Total stockholders'equity -40.89%17.14B-46.78%17.02B-48.18%16.49B-5.25%29.43B-5.25%29.43B-11.24%29B-1.92%31.97B0.77%31.82B-13.59%31.06B-13.59%31.06B
Noncontrolling interests -9.38%58M-5.26%54M-6.45%58M-3.51%55M-3.51%55M1.59%64M-6.56%57M-4.62%62M-5.00%57M-5.00%57M
Total equity -40.82%17.2B-46.71%17.07B-48.10%16.55B-5.25%29.49B-5.25%29.49B-11.22%29.06B-1.93%32.03B0.76%31.89B-13.58%31.12B-13.58%31.12B
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Trending US Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Broadcom
AVGO
+24.43%
Taiwan Semiconductor
TSM
+4.98%
Tesla
TSLA
+4.34%
ASML Holding
ASML
+0.77%
Qualcomm
QCOM
+0.18%

Unlock the Full List

Investment Theme Cancer Research
Cancer Research
Intraday+0.11%